Enhancing Clinical Trials with Patient Interviews: Join the Upcoming Webinar
In an increasing effort to promote patient-centered approaches in drug development, Xtalks invites healthcare professionals and stakeholders to participate in an informative webinar scheduled for June 15, 2026. This free event aims to shed light on the significance of incorporating the patient voice into clinical trials through in-trial patient interviews, an obligation that both the FDA (Food and Drug Administration) and EMA (European Medicines Agency) are emphasizing in their latest guidance. The session addresses how recent updates to the ICH-GCP E6(R3) guidelines have heightened regulatory expectations regarding data integrity and patient safety, ultimately ensuring that the clinical trial process is as thorough and reliable as possible.
Context of In-trial Patient Interviews
The concept of including patient interviews during clinical trials is gaining traction as a valuable means of gathering key insights directly from study participants. By understanding their experiences, motivations, and concerns, researchers can create more effective and safer drugs that truly meet patient needs. However, capturing data that can withstand regulatory scrutiny requires meticulous planning from the very start of the trial process. The upcoming webinar will explore how sponsors can effectively plan these interviews to enhance data readiness and compliance with regulatory standards.
Key Takeaways
Attendees will hear from esteemed speakers Jens Harald Kongsø and Christian Holm, founders of CLINIGMA, who will elaborate on what it means to comply with emerging guidelines. One of the highlights of the session will be a thorough discussion around the need for treating interview recordings as source data, which falls under the same standards of integrity, traceability, and documentation as any other clinical trial data. Furthermore, as the trial setting often spans various countries, the complexities of adhering to local data privacy laws alongside GCP requirements will be addressed in detail.
The session will also provide practical tools, including a complimentary Request for Proposal (RFP) template and evaluation checklist. These resources aim to assist participants in selecting patient interview vendors from the get-go, ensuring they meet the necessary regulatory criteria and ultimately contributing to the integrity of clinical trial data.
The Importance of Patient Safety and Data Integrity
Beyond just technical compliance, the discussion will delve into the broader concepts of patient safety and data integrity. Understanding these concepts in the planning stages is crucial for decisions made regarding interview modalities, data collection techniques, and other best practices that support regulatory expectations. Mistakes made early in the process can have far-reaching consequences, affecting not just the trial but also patient safety and future treatments.
Registration Information
This webinar marks the first of a comprehensive four-part series that looks at the entire lifecycle of in-trial patient interviews. Participants can expect a forum for discussion, learning, and the chance to ask questions about the best practices and habits to adopt in their future trials.
To join this crucial educational experience, register now for the event on June 15, 2026, at 11 AM EDT (5 PM CEST). For more details about the event and registration, be sure to visit Xtalks’ dedicated webpage on planning patient interviews to promote trial data readiness. Join the movement towards more responsible, patient-oriented drug development—your participation matters to the future of healthcare.